1. Home
  2. NVCT vs MEI Comparison

NVCT vs MEI Comparison

Compare NVCT & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • MEI
  • Stock Information
  • Founded
  • NVCT 2020
  • MEI 1946
  • Country
  • NVCT United States
  • MEI United States
  • Employees
  • NVCT N/A
  • MEI N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • MEI Electrical Products
  • Sector
  • NVCT Health Care
  • MEI Technology
  • Exchange
  • NVCT Nasdaq
  • MEI Nasdaq
  • Market Cap
  • NVCT 249.1M
  • MEI 238.4M
  • IPO Year
  • NVCT 2022
  • MEI N/A
  • Fundamental
  • Price
  • NVCT $8.98
  • MEI $7.88
  • Analyst Decision
  • NVCT Strong Buy
  • MEI Buy
  • Analyst Count
  • NVCT 3
  • MEI 2
  • Target Price
  • NVCT $17.00
  • MEI $10.50
  • AVG Volume (30 Days)
  • NVCT 132.1K
  • MEI 223.3K
  • Earning Date
  • NVCT 05-06-2025
  • MEI 07-10-2025
  • Dividend Yield
  • NVCT N/A
  • MEI 7.16%
  • EPS Growth
  • NVCT N/A
  • MEI N/A
  • EPS
  • NVCT N/A
  • MEI N/A
  • Revenue
  • NVCT N/A
  • MEI $1,068,300,000.00
  • Revenue This Year
  • NVCT N/A
  • MEI N/A
  • Revenue Next Year
  • NVCT N/A
  • MEI $1.16
  • P/E Ratio
  • NVCT N/A
  • MEI N/A
  • Revenue Growth
  • NVCT N/A
  • MEI N/A
  • 52 Week Low
  • NVCT $4.44
  • MEI $5.08
  • 52 Week High
  • NVCT $11.80
  • MEI $17.45
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 44.39
  • MEI 63.45
  • Support Level
  • NVCT $9.92
  • MEI $7.72
  • Resistance Level
  • NVCT $11.15
  • MEI $8.05
  • Average True Range (ATR)
  • NVCT 0.64
  • MEI 0.25
  • MACD
  • NVCT -0.09
  • MEI 0.04
  • Stochastic Oscillator
  • NVCT 26.94
  • MEI 81.91

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About MEI Methode Electronics Inc.

Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.

Share on Social Networks: